October, 22 2024, 10:48am EDT

New Roundup weedkiller 45 times more toxic to human health
Friends of the Earth analysis shows cancer-linked glyphosate remains and is joined by new, more dangerous chemicals on 50th anniversary of Roundup
On the fiftieth anniversary of the controversial weedkiller’s release, a Friends of the Earth analysis – New Roundup, New Risks – finds that residential Roundup products are more toxic to consumers and the environment than ever before. Not only has manufacturer Bayer [OTCMKTS: BAYRY] failed to remove glyphosate from all Roundup products, as promised, but new formulations of Roundup are 45 times more toxic to human health, on average, following long-term, chronic exposure. They also pose greater risks to the environment.
Bayer announced it would remove glyphosate from consumer products starting in 2023 in response to tens of thousands of lawsuits linking the weedkiller to non-Hodgkin’s lymphoma. Friends of the Earth reviewed Roundup weedkillers for sale at the two largest U.S. home and garden retailers – Home Depot [NYSE: HD] and Lowe’s [NYSE: LOW] – to determine whether the company followed through as of October, 2024.
Not only do several Roundup products still contain glyphosate, but eight new Roundup products contain chemicals of dramatically greater concern. With no requirement from the Environmental Protection Agency (EPA) to warn consumers of the new dangers, people are unknowingly being exposed to higher risks.
Roundup products sold to consumers now contain combinations of four new active ingredients as replacements for glyphosate: diquat dibromide, fluazifop-P-butyl, triclopyr, and imazapic. All four chemicals pose greater risk of long-term and/or reproductive health problems than glyphosate based on the EPA’s evaluation of safety studies. They have been linked to a variety of harms to human health, including birth and developmental abnormalities; reproductive dysfunction; kidney or liver damage; and irritation, inflammation, or allergic reactions affecting the skin, eyes, and respiratory system. The worst offender is diquat dibromide, found in all of the new Roundup formulations. It is 200 times more chronically toxic than glyphosate, is classified as a highly hazardous pesticide, and is banned in the European Union.
In addition to the threat to human health, the new Roundup weedkillers also endanger animals and the environment. On average, they are more toxic to bees, birds, fish, aquatic organisms, and earthworms. They are also more persistent in the environment and more likely to leach into groundwater, increasing the risk of contaminating waterways and drinking water.
“The human toll of Roundup is enormous – tens of thousands of people have lost their lives and their health because of this toxic weedkiller. With the new formulations of Roundup, Bayer had the opportunity to make us safer, but it did the opposite,” said Kendra Klein, deputy director of science for Friends of the Earth. “Bayer’s willingness to deceive the public and disregard our health as it continues to cash in on the Roundup brand name is outrageous.”
Internal corporate documents unearthed during the Roundup litigation show the profound extent of deceit and disinformation that Monsanto deployed to cover up the dangers of Roundup. Our analysis reveals that Bayer continues to mislead consumers, exposing them to far greater risks with no warning. While the new active ingredients are listed on Roundup product labels, as required by law, there is no language alerting consumers to the higher risks they pose. The average consumer – even if they notice the new ingredients – knows little about the toxicology of glyphosate compared to the new ingredients that are taking its place.
“Drug companies are not allowed to replace the aspirin in a brand-name pain reliever with oxycontin or fentanyl, and for good reason. It is unconscionable that the Environmental Protection Agency allows this toxic sleight of hand and unethical that Bayer is exposing consumers to dramatically greater risks with no warning,” said Sarah Starman, senior campaigner at Friends of the Earth. “Bayer, like other chemical companies, cannot be trusted to protect our health. We need serious reform at the EPA to ensure that the agency does its duty to protect people and the environment from dangerous pesticides.”
Garden retailers like Lowe’s and Home Depot also have an important role to play in protecting consumers. Based on the findings of this analysis, they should immediately remove all Roundup products from shelves and online sales, aggressively work to phase out other hazardous pesticide products they sell, and increase offerings of organic and other safer options. At the bare minimum, they should ensure labels and point-of-purchase information on Roundup products accurately conveys the nature and levels of new risks. Over 120 organizations have called on Home Depot and Lowe’s to take action to #RejectRoundup and make their garden product shelves safer overall.
Friends of the Earth fights for a more healthy and just world. Together we speak truth to power and expose those who endanger the health of people and the planet for corporate profit. We organize to build long-term political power and campaign to change the rules of our economic and political systems that create injustice and destroy nature.
(202) 783-7400LATEST NEWS
Trump's 9 New Prescription Drug Deals 'No Substitute' for Systemic Reform
"Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices," said one campaigner.
Dec 19, 2025
"Starting next year, American drug prices will come down fast and furious and will soon be the lowest in the developed world," President Donald Trump claimed Friday as the White House announced agreements with nine pharmaceutical manufacturers.
The administration struck most favored nation (MFN) pricing deals with Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi. The president—who has launched the related TrumpRx.gov—previously reached agreements with AstraZeneca, EMD Serono, Eli Lilly, Novo Nordisk, and Pfizer.
"The White House said it has made MFN deals with 14 of the 17 biggest drug manufacturers in the world," CBS News noted Friday. "The three drugmakers that were not part of the announcement are AbbVie, Johnson & Johnson, and Regeneron, but the president said that deals involving the remaining three could be announced at another time."
However, as Trump and congressional Republicans move to kick millions of Americans off of Medicaid and potentially leave millions more uninsured because they can't afford skyrocketing premiums for Affordable Care Act (ACA) plans, some critics suggested that the new drug deals with Big Pharma are far from enough.
"When 47% of Americans are concerned they won't be able to afford a healthcare cost next year, steps to reduce drug prices for patients are welcomed, especially by patients who rely on one of the overpriced essential medicines named in today's announcement," said Merith Basey, CEO of Patients for Affordable Drugs Now, in a statement.
"But voluntary agreements with drug companies—especially when key details remain undisclosed—are no substitute for durable, system-wide reforms," Basey stressed. "Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices, because drugs don't work if people can't afford them."
As the New York Times reported Friday:
Drugs that will be made available in this way include Amgen's Repatha, for lowering cholesterol, at $239 a month; GSK's asthma inhaler, Advair Diskus, at $89 a month; and Merck's diabetes medication Januvia, at $100 a month.
Many of these drugs are nearing the end of their patent protection, meaning that the arrival of low-cost generic competition would soon have prompted manufacturers to lower their prices.
In other cases, the direct-buy offerings are very expensive and out of reach for most Americans.
For example, Gilead will offer Epclusa, a three-month regimen of pills that cures hepatitis C, for $2,492 a month on the site. Most patients pay far less using insurance or with help from patient assistance programs. Gilead says on its website that "typically a person taking Epclusa pays between $0 and $5 per month" with commercial insurance or Medicare.
While medication prices are a concern for Americans who face rising costs for everything from groceries to utility bills, the outcome of the ongoing battle on Capitol Hill over ACA tax credits—which are set to expire at the end of the year—is expected to determine how many people can even afford to buy health insurance for next year.
The ACA subsidies fight—which Republicans in the US House of Representatives ignored in the bill they passed this week before leaving Capitol Hill early—has renewed calls for transitioning the United States from its current for-profit healthcare system to Medicare for All.
"At the heart of our healthcare crisis is one simple truth: Corporations have too much power over our lives," Rep. Pramila Jayapal (D-Wash.), former chair of the Congressional Progressive Caucus, said on social media Friday. "Medicare for All is how we take our power back and build a system that puts people over profits."
Jayapal reintroduced the Medicare for All Act in April with Rep. Debbie Dingell (D-Mich.) and Senate Health, Education, Labor, and Pensions Committee Ranking Member Bernie Sanders (I-Vt.). The senator said Friday that some of his top priorities in 2026 will be campaign finance reform, income and wealth inequality, the rapid deployment of artificial intelligence, and Medicare for All.
Earlier this month, another backer of that bill, US Sen. Chris Van Hollen (D-Md.), said: "We must stop tinkering around the edges of a broken healthcare system. Yes, let's extend the ACA tax credits to prevent a huge spike in healthcare costs for millions. Then, let's finally create a system that puts your health over corporate profits. We need Medicare for All."
It's not just progressives in Congress demanding that kind of transformation. According to Data for Progress polling results released late last month, 65% of likely US voters—including 78% of Democrats, 71% of Independents, and 49% of Republicans—either strongly or somewhat support "creating a national health insurance program, sometimes called 'Medicare for All.'"
Keep ReadingShow Less
Trump: US Forces 'Striking Very Strongly' Against 70+ Targets in Syria
"Most anti-war president ever, also a winner of the FIFA Peace Prize, threatened to invade Venezuela for oil earlier this week and has now launched strikes in Syria," said one observer.
Dec 19, 2025
President Donald Trump—the self-described "most anti-war president in history"—on Friday said the US military is "striking very strongly" against Islamic State strongholds in Syria following the killing of two Iowa National Guard members and an American civilian interpreter in the Mideast nation.
"Because of ISIS’s vicious killing of brave American Patriots in Syria, whose beautiful souls I welcomed home to American soil earlier this week in a very dignified ceremony, I am hereby announcing that the United States is inflicting very serious retaliation, just as I promised, on the murderous terrorists responsible," Trump said on his Truth Social network.
"We are striking very strongly against ISIS strongholds in Syria, a place soaked in blood which has many problems, but one that has a bright future if ISIS can be eradicated," the president continued. "The Government of Syria, led by a man who is working very hard to bring Greatness back to Syria, is fully in support."
"All terrorists who are evil enough to attack Americans are hereby warned—YOU WILL BE HIT HARDER THAN YOU HAVE EVER BEEN HIT BEFORE IF YOU, IN ANY WAY, ATTACK OR THREATEN THE U.S.A.," he added.
US Defense Secretary Pete Hegseth said on X that "earlier today, US forces commenced OPERATION HAWKEYE STRIKE in Syria to eliminate ISIS fighters, infrastructure, and weapons sites in direct response to the attack on US forces that occurred on December 13th in Palmyra, Syria."
According to the Wall Street Journal, Jordanian warplanes also took part in Friday's attacks, which reportedly hit more than 70 targets in Syria.
"This is not the beginning of a war—it is a declaration of vengeance," said Hegseth. "The United States of America, under President Trump’s leadership, will never hesitate and never relent to defend our people. As we said directly following the savage attack, if you target Americans—anywhere in the world—you will spend the rest of your brief, anxious life knowing the United States will hunt you, find you, and ruthlessly kill you. Today, we hunted and we killed our enemies. Lots of them. And we will continue."
US Central Command (CENTCOM) said that one of Friday's airstrikes killed ISIS leader Abu Yusif in Dayr az Zawr province in eastern Syria.
“As stated before, the United States—working with allies and partners in the region—will not allow ISIS to take advantage of the current situation in Syria and reconstitute," CENTCOM commander Gen. Michael Erik Kurilla said in a statement. "ISIS has the intent to break out of detention the over 8,000 ISIS operatives currently being held in facilities in Syria. We will aggressively target these leaders and operatives, including those trying to conduct operations external to Syria."
During his first term, Trump followed through on his promise to "bomb the shit out of" ISIS militants in Syria and Iraq, killing thousands of civilians in a campaign launched by former President Barack Obama in 2014. Trump prematurely declared victory over ISIS in 2018.
Since then, the Biden and Trump administrations have bombed Syria, where around 1,000 US troops remain.
During his second term, Trump has ordered attacks on Iran, Somalia, Syria, Yemen, and boats allegedly transporting drugs in the Caribbean Sea and Pacific Ocean. The president—who says he deserves a Nobel Peace Prize—has also deployed warships and thousands of troops for a possible war on Venezuela.
"Most anti-war president ever, also a winner of the FIFA Peace Prize, threatened to invade Venezuela for oil earlier this week and has now launched strikes in Syria," political commentator David Pakman said on X in response to Friday's attacks.
Some observers noted that the strikes on Syria took place on the same day that the Trump administration released some of the files related to the late convicted sex criminal and longtime former Trump friend Jeffrey Epstein.
Keep ReadingShow Less
Mitt "47%" Romney's Post-Career Call to Tax the Rich Met With Kudos and Criticism
"When Romney had real power," noted journalist David Sirota, "he fortified the rigged tax system that he's only now criticizing from the sidelines."
Dec 19, 2025
In a leaked fundraiser footage from the 2012 US presidential campaign, Republican candidate Mitt Romney infamously claimed that 47% of Americans are people "who believe that they are victims, who believe that government has a responsibility to care for them, who believe that they are entitled to healthcare, to food, to housing, to you name it." On Friday, the former US senator from Utah published a New York Times opinion piece titled, "Tax the Rich, Like Me."
"In 2012, political ads suggested that some of my policy proposals, if enacted, would amount to pushing grandma off a cliff. Actually, my proposals were intended to prevent that very thing from happening," Romney began the article, which was met with a range of reactions. "Today, all of us, including our grandmas, truly are headed for a cliff: If, as projected, the Social Security Trust Fund runs out in the 2034 fiscal year, benefits will be cut by about 23%."
"Typically, Democrats insist on higher taxes, and Republicans insist on lower spending. But given the magnitude of our national debt as well as the proximity of the cliff, both are necessary," he argued. "On the spending-cut front... Social Security and Medicare benefits for future retirees should be means-tested—need-based, that is to say—and the starting age for entitlement payments should be linked to American life expectancy."
"And on the tax front, it's time for rich people like me to pay more," wrote Romney, whose estimated net worth last year, when he announced his January 2025 retirement from the Senate, was $235 million. "I long opposed increasing the income level on which FICA employment taxes are applied (this year, the cap is $176,100). No longer; the consequences of the cliff have changed my mind."
"The largest source of additional tax revenues is also probably the most compelling for fairness and social stability. Some call it closing tax code loopholes, but the term 'loopholes' grossly understates their scale. 'Caverns' or 'caves' would be more fitting," he continued, calling for rewriting capital gains tax treatment rules for "mega-estates over $100 million."
"Sealing the real estate caverns would also raise more revenue," Romney noted. "There are more loopholes and caverns to be explored and sealed for the very wealthy, including state and local tax deductions, the tax rate on carried interest, and charity limits on the largest estates at death."
Some welcomed or even praised Romney's piece. Iowa state Rep. JD Scholten (D-1), a progressive who has previously run for both chambers of Congress, declared on social media: "Tax the rich! Welcome to the coalition, Mitt!"
US House Committee on the Budget Ranking Member Brendan Boyle (D-Pa.), who is part of the New Democrat Coalition, said: "I welcome this op-ed by Mitt Romney and encourage people to read it. As the next chair of the House Budget Committee, increasing revenue by closing loopholes exploited by the wealthiest Americans will be a top priority."
Progressive Saikat Chakrabarti, who is reportedly worth at least $167 million and is one of the candidates running to replace retiring former House Speaker Nancy Pelosi (D-Calif.), responded: "Even Mitt Romney now agrees that we need to tax the wealthiest. I call for a wealth tax on our billionaires and centimillionaires."
Michael Linden, a senior policy fellow at the Washington Center for Equitable Growth, said: "Kudos to Mitt Romney for changing his mind and calling for higher taxes on the rich. I'm not going to nitpick his op-ed (though there are a few things I disagree with), because the gist of it is right: We need real tax reform to make the rich pay more."
Others pointed to Romney's record, including the impactful 47% remarks. The Lever's David Sirota wondered, "Why is it that powerful people typically wait until they have no power to take the right position and effectively admit they were wrong when they had more power to do something about it?"
According to Sirota:
The obvious news of the op-ed is that we've reached a point in which even American politics' very own Gordon Gekko—a private equity mogul-turned-Republican politician—is now admitting the tax system has been rigged for his fellow oligarchs.
And, hey, that's good. I believe in the politics of addition. I believe in welcoming converts to good causes in the spirit of "better late than never." I believe there should be space for people to change their views for the better. And I appreciate Romney offering at least some pro forma explanation about what allegedly changed his thinking (sidenote: I say "allegedly" because it's not like Romney only just now learned that the tax system was rigged—he was literally a co-founder of Bain Capital!).
"And yet, these kinds of reversals (without explicit apologies, of course) often come off as both long overdue but also vaguely inauthentic, or at least not as courageous and principled as they seem," Sirota continued, stressing that "when Romney had real power, he fortified the rigged tax system that he's only now criticizing from the sidelines."
Keep ReadingShow Less
Most Popular


